Implications of Inconsistent Measurement of ER Status in Non‐Invasive Breast Cancer: A Study of 1,684 Cases from the Sloane Project

J Thomas, A Hanby, S Pinder, I Ellis… - The breast …, 2008 - Wiley Online Library
The Sloane Project is an anonymized UK‐wide audit of screen‐detected atypical
hyperplasia and in situ carcinoma of the breast. Full histopathology data have been …

Consistency of histopathological reporting of breast lesions detected by screening: findings of the UK National External Quality Assessment (EQA) Scheme

UKNCG for Breast, JP Sloane, R Ellman… - European journal of …, 1994 - Elsevier
The aim of the scheme was to determine consistency of histopathological reporting in the
United Kingdom National Breast Screening Programme. This external quality assessment …

[HTML][HTML] Hormone-and HER2-receptor assessment in 33,046 breast cancer patients: a nationwide comparison of positivity rates between pathology laboratories in the …

C van Dooijeweert, IAG Deckers, IO Baas… - Breast Cancer Research …, 2019 - Springer
Purpose Patient management of invasive breast cancer (IBC) is to a large extent based on
hormone-and HER2-receptor assessment. High-quality, reliable receptor assessment is of …

Hormone receptor status in primary breast cancer—time for a consensus?

GC Wishart, M Gaston, AA Poultsidis… - European Journal of …, 2002 - Elsevier
In a previous study, we demonstrated wide variability in the access to oestrogen receptor
(ER) measurement, patient selection, choice of technique and the cut-off point for positivity …

Immunohistochemical assessment of hormone receptor status using a new scoring system (J-Score) in breast cancer

M Kurosumi - Breast cancer, 2007 - Springer
The assessment of hormone receptor status in breast cancer is essential to decide whether
endocrine therapy is indicated or not. Immunohistochemistry (IHC) is thought to be the best …

Estrogen and progesterone receptor testing in breast cancer: ASCO/CAP guideline update

KH Allison, MEH Hammond, M Dowsett… - Journal of Clinical …, 2020 - ascopubs.org
PURPOSE To update key recommendations of the American Society of Clinical
Oncology/College of American Pathologists estrogen (ER) and progesterone receptor (PgR) …

Estrogen and progesterone receptor testing in breast cancer: American Society of Clinical Oncology/College of American Pathologists guideline update

KH Allison, MEH Hammond… - … of pathology & …, 2020 - meridian.allenpress.com
Purpose.—To update key recommendations of the American Society of Clinical
Oncology/College of American Pathologists estrogen receptor (ER) and progesterone …

[HTML][HTML] Hormone receptors in breast cancer: Clinical utility and guideline recommendations to improve test accuracy

MEH Hammond - 2014 - medilib.ir
INTRODUCTION—The importance of steroid hormone receptors to the biology of breast
cancer was recognized over 40 years ago, when it was observed that radiolabeled …

ER and PR Immunohistochemistry and HER 2 FISH versus Oncotype DX: Implications for Breast Cancer Treatment

MHM Park, JJ Ebel, W Zhao, DL Zynger - The Breast Journal, 2014 - Wiley Online Library
Estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor
(HER 2) concordance between immunohistochemistry (IHC) and fluorescence in situ …

Assessment of estrogen receptor low positive status in breast cancer: Implications for pathologists and oncologists

N Fusco, M Ragazzi, E Sajjadi, K Venetis… - Histology and …, 2021 - iris.unimore.it
Estrogen receptor (ER) status assessment by immunohistochemistry (IHC) is the gold
standard test for the identification of patients with breast cancer who may benefit from …